Biotech & Investor Happy Hour January 30th

Are you an early-stage investor? 

Do you have a company and want to take it public?

Join us for casual conversation, drinks and appetizers on Wednesday, January 30th from 4-7PM

InSitu Biologics & Manhattan Street Capital brings you expert insight on raising capital in Biotech and Life Sciences. Plus, network with other local companies & investors.


4:00PM – 4:30PM Networking

4:30PM – 4:45PM Welcome / Introduction

4:45PM – 5:05PM Breakaway Session #1

5:15PM – 5:35PM Breakaway Session #2

5:45PM – 7:00PM Networking

Session #1 – Regulation A+ public offering

Rod Turner, CEO Manhattan Street Capital

San Diego-based Manhattan Street Capital

Session #2 – InSitu Biologics ? Matrix BioHydrogel? & AnestaGel?

Jim Segermark, CEO InSitu Biologics

Non-Opiate Painkiller, over 22+ Patents Issued, Market Cap of Only $77 million

About InSitu Biologics

InSitu Biologics is an emerging biotech company, with a highly developed non-opiate painkiller that is expected to be studied in people this year. Nearly $3m raised with Manhattan Street Capital using Regulation A+.

About Manhattan Street Capital

Manhattan Street Capital is the premier online fundraising platform for Regulation A+ and Private Offerings.


For more information contact

Jim Segermark, CEO of InSitu Biologics

1-651-338-4801 |

From Jan 30, 2019 04:00PM to Jan 30, 2019 07:00PM at Prado, 1549 El Prado, San Diego, CA 92101, USA (Garden Terrace)